VANSEN PHARMA INC.
CIK 0001378076
Revenue (TTM)
—
Q3 Dec 2013
Net Income (TTM)
−$37.15K
−48.2% YoY
Q3 Dec 2013
EPS Diluted (TTM)
—
Q3 Dec 2013
Gross Margin
—
Q3 Dec 2013
Operating Margin
—
Q3 Dec 2013
Net Margin
—
Q3 Dec 2013
Free Cash Flow (TTM)
—
Q3 Dec 2013
Cash
$176
Q3 Dec 2013
Total Debt
$1.08M
Q3 Dec 2013
Shares Outstanding
85.8M sh
Q3 Dec 2013
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.